Michael Kelly

Michael Kelly

Director/Board Member bij PRIME MEDICINE, INC.

Vermogen: 1 M $ op 31-03-2024

67 jaar
Health Technology
Health Services
Industrial Services

Profiel

Mr. Michael A.
Kelly is an Independent Director at Prime Medicine, Inc., an Independent Director at Amicus Therapeutics, Inc., an Independent Director at DMC Global, Inc., a Lead Independent Director at NeoGenomics, Inc. and a President at Sentry Hill Partners LLC.
He is on the Board of Directors at Chroma Medicine, Inc., Prime Medicine, Inc., Amicus Therapeutics, Inc., DMC Global, Inc., NeoGenomics, Inc., NeoGenomics Laboratories, Inc. and Hookipa Biotech AG.
Mr. Kelly was previously employed as an Independent Director by Aprea Therapeutics, Inc., an Independent Director by HOOKIPA Pharma, Inc., a Senior Vice President-Global Business Services by Amgen, Inc., a Chief Financial Officer by Tanox, Inc., a Vice President-Finance & Controller by Biogen Idec, Inc., a Chief Financial Officer & Vice President-Finance by Nutrasweet Kelco Co. Ltd., a Chief Financial Officer & Vice President by The NutraSweet Co., a Principal by Onyx Capital Management LLC, and a Chief Financial Officer by Monsanto Life Sciences Co. He also served on the board at Direct Relief.
He received his undergraduate degree from Florida A&M University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
08-06-2023 40 207 ( 0.01% ) 473 638 $ 31-03-2024
10-08-2023 20 419 ( 0.02% ) 320 987 $ 31-03-2024
21-03-2024 16 035 ( 0.08% ) 312 522 $ 31-03-2024
04-04-2023 5 754 ( 0.01% ) 4 097 $ 31-03-2024
14-06-2023 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Michael Kelly

BedrijvenFunctieBegin
NEOGENOMICS, INC. Director/Board Member 15-07-2020
DMC GLOBAL INC. Director/Board Member 24-07-2020
AMICUS THERAPEUTICS, INC. Director/Board Member 01-12-2020
PRIME MEDICINE, INC. Director/Board Member 01-11-2021
Director/Board Member 01-07-2020
Sentry Hill Partners LLC Founder 01-01-2018
Director/Board Member 15-02-2019
Director/Board Member 27-09-2023
Alle actieve functies van Michael Kelly

Eerdere bekende functies van Michael Kelly

BedrijvenFunctieEinde
HOOKIPA PHARMA INC. Director/Board Member 07-04-2023
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Michael Kelly in detail bekijken

Opleiding van Michael Kelly

Florida A&M University Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Michael Kelly in detail bekijken

Connecties

100 +

Eerstegraads connecties

19

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven7
AMGEN INC.

Health Technology

DMC GLOBAL INC.

Industrial Services

BIOGEN INC.

Health Technology

NEOGENOMICS, INC.

Health Services

AMICUS THERAPEUTICS, INC.

Health Technology

HOOKIPA PHARMA INC.

Health Technology

APREA THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit11

Health Technology

Finance

Process Industries

Commercial Services

Monsanto Life Sciences Co.

Health Technology

Health Services

Sentry Hill Partners LLC

Prime Medicine, Inc.

Health Technology

Nutrasweet Kelco Co. Ltd.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Michael Kelly